摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(2-Aminoethyl)cyclopent-4-ene-1,3-dione

中文名称
——
中文别名
——
英文名称
2-(2-Aminoethyl)cyclopent-4-ene-1,3-dione
英文别名
2-(2-aminoethyl)cyclopent-4-ene-1,3-dione
2-(2-Aminoethyl)cyclopent-4-ene-1,3-dione化学式
CAS
——
化学式
C7H9NO2
mdl
——
分子量
139.15
InChiKey
WYIWDXYZPPZAGK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.6
  • 重原子数:
    10
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    60.2
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • CONJUGATES COMPRISING CELL-BINDING AGENTS AND CYTOTOXIC AGENTS
    申请人:IMMUNOGEN, INC.
    公开号:US20150359904A1
    公开(公告)日:2015-12-17
    The invention provides linker compounds and cytotoxic compounds that are useful for forming a CBA-drug conjugates; and conjugates so formed. Such conjugates and/or cytotoxic compounds may be effective for treating a range of diseases, such as cancer, with a relatively high activity at a relatively low, non-toxic dose.
  • ANTI-CD123 ANTIBODIES AND CONJUGATES AND DERIVATIVES THEREOF
    申请人:ImmunoGen, Inc.
    公开号:US20170029514A1
    公开(公告)日:2017-02-02
    The present invention generally relates to antibodies, antigen-binding fragments thereof, polypeptides, and immunoconjugates that bind to CD123 antigen (the α chain of the interleukine 3 receptor, or IL-3Rα). The present invention also relates to methods of using such CD123-binding molecules for diagnosing and treating diseases, such as B-cell malignancies.
  • [EN] CONJUGATES COMPRISING CELL-BINDING AGENTS AND CYTOTOXIC AGENTS<br/>[FR] CONJUGUÉS COMPRENANT DES AGENTS DE LIAISON CELLULAIRE (CBA) ET DES AGENTS CYTOTOXIQUES
    申请人:IMMUNOGEN INC
    公开号:WO2014134486A2
    公开(公告)日:2014-09-04
    The invention provides linker compounds and cytotoxic compounds that are useful for forming a CBA-drug conjugates; and conjugates so formed. Such conjugates and/or cytotoxic compounds may be effective for treating a range of diseases, such as cancer, with a relatively high activity at a relatively low, non-toxic dose.
查看更多